NK
Latigo Biotherapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| LTG-001 | Pain (specific type not disclosed) | Phase 1 |
Leadership Team at Latigo Biotherapeutics
NF
Nima Farzan
Chief Executive Officer
NS
Neil Singla, M.D.
Chief Medical Officer
TP
Timothy P. Walbert
Chair, Board of Directors